SoftBank Group Corp. tumbled to a loss in the December quarter, weighed down by a drop in the value of the Vision Fund’s public holdings, just as Masayoshi Son campaigns to raise $500 billion for the ...

Japan's SoftBank Group booked a surprise $2.4 billion quarterly loss on Wednesday, hit by a decline in the value of e-commerce platform Coupang and other tech companies held by its Vision Fund ...

Billionaire Masayoshi Son, founder and CEO of Japanese multinational investment company SoftBank Group, is one of the richest people in the world. Considered one of the most powerful investors in the ...

SoftBank's telco arm remains strong despite challenges, but high-risk AI ventures and premium valuations pose significant near-term investment risks. Learn more on SOBKY stock here.

NVIDIA's continued investment in Recursion Pharmaceuticals strengthens the view that Recursion is a favored investment within ...

SoftBank Group OpenAI as a lead partners and we have ... And as technology partners, we have of course NVIDIA, Microsoft Oracle together with OpenAI those are the industry leaders is going to ...

SoftBank Group posted a surprise quarterly loss Wednesday and the Japanese company’s revenue also missed analysts’ estimates.

SoftBank Group posted a surprise quarterly loss Wednesday and the Japanese company’s revenue also missed analysts’ estimates.

SoftBank Group posted a surprise quarterly loss Wednesday and the Japanese company’s revenue also missed analysts’ estimates.

Nvidia has trimmed its nascent investment portfolio by around 30%, including a big change in a key holding of a former ...

Shares of Recursion Pharmaceuticals closed 23.88% higher on Friday, marking their best single-day gain in nearly two years.